Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.
Enterovirus
HLA class I
LDH assay
Persistence
Type 1 diabetes
Journal
Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
21
11
2018
accepted:
29
05
2019
revised:
19
05
2019
pubmed:
7
6
2019
medline:
29
1
2020
entrez:
8
6
2019
Statut:
ppublish
Résumé
It has been suggested that the persistence of coxsackieviruses-B (CV-B) in pancreatic beta cells plays a role in the pathogenesis of type 1 diabetes (T1D). Yet, immunological effectors, especially natural killer (NK) cells, are supposed to clear virus-infected cells. Therefore, an evaluation of the response of NK cells to pancreatic beta cells persistently infected with CV-B4 was conducted. A persistent CV-B4 infection was established in 1.1B4 pancreatic beta cells. Infectious particles were found in supernatants throughout the culture period. The proportion of cells containing viral protein VP1 was low (< 5%), although a large proportion of cells harbored viral RNA (around 50%), whilst cell viability was preserved. HLA class I cell surface expression was downregulated in persistently infected cultures, but HLA class I mRNA levels were unchanged in comparison with mock-infected cells. The cytolytic activities of IL-2-activated non-adherent peripheral blood mononuclear cells (PBMCs) and of NK cells were higher towards persistently infected cells than towards mock-infected cells, as assessed by an LDH release assay. Impaired cytolytic activity of IL-2-activated non-adherent PBMCs from patients with T1D towards infected beta cells was observed. In conclusion, pancreatic beta cells persistently infected with CV-B4 can be lysed by NK cells, implying that impaired cytolytic activity of these effector cells may play a role in the persistence of CV-B in the host and thus in the viral pathogenesis of T1D.
Identifiants
pubmed: 31172216
doi: 10.1007/s00018-019-03168-4
pii: 10.1007/s00018-019-03168-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
179-194Subventions
Organisme : EU FP7
ID : GA-261441-PEVNET: Persistent virus infection as a cause of pathogenic inflammation in type 1 diabetes - an innovative research program of biobanks
Organisme : EU FP7
ID : expertise
Organisme : Campus France
ID : EIFFEL-DOCTORAT 2017 / n°P714914K
Organisme : Université Lille 2 (FR)
ID : CABRI 2016
Références
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5115-20
pubmed: 17360338
J Mol Cell Cardiol. 1995 Oct;27(10):2199-208
pubmed: 8576936
Int J Cancer. 2006 Jan 1;118(1):129-38
pubmed: 16003759
Cell Mol Life Sci. 2013 Nov;70(21):4169-80
pubmed: 23775130
J Virol. 2005 Apr;79(7):4382-95
pubmed: 15767438
Diabetes. 2011 Jan;60(1):276-9
pubmed: 20943747
Diabetologia. 1987 Dec;30(12):907-11
pubmed: 3436487
Mol Immunol. 2005 Feb;42(4):405-11
pubmed: 15607791
Annu Rev Immunol. 1999;17:189-220
pubmed: 10358757
Diabetes. 2011 Mar;60(3):857-66
pubmed: 21270236
J Biol Chem. 2006 May 19;281(20):14144-50
pubmed: 16540472
BMC Cancer. 2007 Feb 23;7:34
pubmed: 17319941
Immunol Cell Biol. 1999 Feb;77(1):64-75
pubmed: 10101688
Diabetologia. 2004 Feb;47(2):225-39
pubmed: 14727023
J Virol. 2011 Dec;85(24):13409-19
pubmed: 21976640
J Autoimmun. 2006 Mar;26(2):104-15
pubmed: 16431079
Br Med J (Clin Res Ed). 1986 Jul 26;293(6541):244
pubmed: 3089475
J Infect Dis. 1992 Nov;166(5):958-65
pubmed: 1328409
Diabetologia. 2009 Jun;52(6):1143-51
pubmed: 19266182
Diabetes. 2007 Jan;56(1):177-85
pubmed: 17192480
Antiviral Res. 2018 Nov;159:130-133
pubmed: 30290197
Diabetes. 2002 Jun;51(6):1964-71
pubmed: 12031987
Clin Exp Immunol. 1986 Jul;65(1):128-39
pubmed: 3098471
J Biol Chem. 2011 Jun 24;286(25):21982-92
pubmed: 21515691
Nat Rev Microbiol. 2004 Apr;2(4):301-14
pubmed: 15031729
Sci Rep. 2017 Apr 3;7(1):524
pubmed: 28373665
BMJ. 2011 Feb 03;342:d35
pubmed: 21292721
J Immunol. 1986 Sep 1;137(5):1695-702
pubmed: 3018079
Eur J Clin Invest. 2015 Sep;45(9):918-24
pubmed: 26108863
Antiviral Res. 2015 Apr;116:51-4
pubmed: 25655448
Nature. 2001 Dec 13;414(6865):792-8
pubmed: 11742411
J Gen Virol. 2017 Oct;98(10):2421-2422
pubmed: 28884666
Diabetologia. 1986 Jun;29(6):352-7
pubmed: 3527835
Nat Rev Endocrinol. 2010 May;6(5):279-89
pubmed: 20351698
J Immunol. 1987 Aug 1;139(3):913-8
pubmed: 3036947
Viral Immunol. 2010 Feb;23(1):99-104
pubmed: 20121407
Diabetologia. 2011 Sep;54(9):2417-20
pubmed: 21597997
Discov Med. 2014 Nov;18(100):273-82
pubmed: 25425468
Pancreas. 1992;7(4):460-4
pubmed: 1322538
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):1005-1015
pubmed: 29450544
Int J Mol Sci. 2018 Mar 10;19(3):null
pubmed: 29534427
Mol Immunol. 2005 Feb;42(4):501-10
pubmed: 15607806
Cell. 1997 Nov 14;91(4):443-6
pubmed: 9390553
J Mol Biol. 2013 Dec 13;425(24):5020-31
pubmed: 24120940
J Clin Endocrinol Metab. 1986 Jun;62(6):1101-9
pubmed: 3084532
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Diabetes. 1978 Jul;27(7):778-81
pubmed: 350678
Virulence. 2017 Oct 3;8(7):1229-1244
pubmed: 28112573
Apoptosis. 2015 Mar;20(3):263-72
pubmed: 25604067
Diabetes. 2015 May;64(5):1682-7
pubmed: 25422108
J Clin Endocrinol Metab. 2000 Jan;85(1):432-40
pubmed: 10634421
J Virol. 2006 Jul;80(13):6637-47
pubmed: 16775351
Viruses. 2015 Nov 24;7(11):6067-79
pubmed: 26610550
Diabetes Res Clin Pract. 1994 Feb;23(1):37-42
pubmed: 7516851
Cell Microbiol. 2008 Feb;10(2):426-36
pubmed: 17961184
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13790-5
pubmed: 11095746
Nat Immunol. 2002 Apr;3(4):373-82
pubmed: 11919579
Curr Opin Infect Dis. 2013 Jun;26(3):263-9
pubmed: 23549392
Diabetes. 2012 Mar;61(3):687-91
pubmed: 22315304
J Clin Lab Immunol. 1993;40(2):47-60
pubmed: 7932628
World J Gastroenterol. 2004 Feb 15;10(4):514-20
pubmed: 14966908
Diabetes. 2012 Jul;61(7):1661-3
pubmed: 22723273
J Virol. 2000 Nov;74(21):10153-64
pubmed: 11024144
J Med Virol. 2001 Aug;64(4):487-98
pubmed: 11468734
J Virol. 2007 Jul;81(13):6785-97
pubmed: 17442717
Endocr Pathol. 2014 Mar;25(1):80-92
pubmed: 24522639